Revance(RVNC) Prnewswire·2025-02-20 10:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Revance Therapeutics, Inc. regarding a class action lawsuit due to alleged misleading statements and material breaches related to a Distribution Agreement with Teoxane [1]. Group 1: Allegations - The complaint alleges that Revance was in material breach of the Distribution Agreement with Teoxane, which granted Revance exclusive rights to import, market, promote, sell, and distribute Teoxane's dermal fillers [1]. - The breach subjected the company to increased risks of litigation, monetary, and reputational harm [1]. - The allegations suggest that these issues increased the risk of delays or amendments to a tender offer, rendering the company's public statements materially false and misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is from February 29, 2024, to December 6, 2024, and shareholders are encouraged to register for participation [1][2]. - The deadline for shareholders to seek lead plaintiff status is March 4, 2025, and there is no cost or obligation to participate in the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that artificially inflate stock prices [3].